MwanzoALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Bei iliyotangulia
$ 10.17
Bei za siku
$ 10.17 - $ 10.31
Bei za mwaka
$ 9.15 - $ 13.14
Thamani ya kampuni katika soko
2.83T JPY
Wastani wa hisa zilizouzwa
elfu 156.05
Habari za soko
TipRanks
saa 9 zilizopita
Microsoft (NASDAQ:MSFT) Stock: Turn the Dip into a Golden Buying Opportunity
1.17%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 462.50B | 17.94% |
Matumizi ya uendeshaji wa biashara | 341.78B | 7.88% |
Mapato halisi | 35.91B | 1,239.35% |
Kiwango cha faida halisi | 7.76 | 1,041.18% |
Mapato kwa kila hisa | — | — |
EBITDA | 88.05B | 120.73% |
Asilimia ya kodi ya mapato | 6.85% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 292.99B | -12.28% |
Jumla ya mali | 3.46T | -2.28% |
Jumla ya dhima | 1.93T | 1.51% |
Jumla ya hisa | 1.53T | — |
hisa zilizosalia | 1.79B | — |
Uwiano wa bei na thamani | 0.01 | — |
Faida inayotokana na mali | 2.64% | — |
Faida inayotokana mtaji | 3.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 35.91B | 1,239.35% |
Pesa kutokana na shughuli | 64.81B | 75.72% |
Pesa kutokana na uwekezaji | -16.38B | 97.88% |
Pesa kutokana na ufadhili | -54.34B | -110.76% |
Mabadiliko halisi ya pesa taslimu | -9.94B | 95.63% |
Mtiririko huru wa pesa | 43.59B | -17.69% |
Kuhusu
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Apr 2005
Makao Makuu
Tovuti
Wafanyakazi
14,754
